Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas.
暂无分享,去创建一个
E. Campo | E. Montserrat | P. Jares | M. Pinyol | C. López-Otín | M. Balbín | P. Fernández | A. Cardesa | L. Hernández | M. Cazorla | P. Fernández | P. Fernandez | Luís Hernández
[1] N. Harris,et al. Expression of the Retinoblastoma Protein in Low-Grade B-Cell Lymphoma: Relationship to Cyclin D1 , 1996 .
[2] W. Chan,et al. p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. , 1996, Blood.
[3] E. Campo,et al. Detection of the bcl-1 rearrangement at the major translocation cluster in frozen and paraffin-embedded tissues of mantle cell lymphomas by polymerase chain reaction. , 1996, American journal of clinical pathology.
[4] F. Bosch,et al. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity. , 1996, The American journal of pathology.
[5] F. Bosch,et al. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. , 1996, Blood.
[6] L. Chin,et al. Role of the INK4a Locus in Tumor Suppression and Cell Mortality , 1996, Cell.
[7] N. Harris,et al. Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1. , 1996, Blood.
[8] F. Bosch,et al. Increased expression of the PRAD‐1/CCND1 gene in hairy cell leukaemia , 1995, British journal of haematology.
[9] J. Bartek,et al. Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control. , 1995, Cancer research.
[10] Y. Xiong,et al. Deletion of cyclin-dependent kinase 4 inhibitor genes P15 and P16 in non-Hodgkin's lymphoma , 1995 .
[11] D C Louie,et al. p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32). , 1995, Blood.
[12] F. Miller,et al. Tumor suppression by p21WAF1. , 1995, Cancer research.
[13] N. Harris,et al. Expression of cyclin D1 protein in centrocytic/mantle cell lymphomas with and without rearrangement of the BCL1/cyclin D1 gene. , 1995, Human pathology.
[14] H. Koeffler,et al. Role of the cyclin-dependent kinase inhibitors in the development of cancer. , 1995, Blood.
[15] R. Weinberg,et al. Growth suppression by p16ink4 requires functional retinoblastoma protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[16] J. Herman,et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.
[17] L. Tsai,et al. Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[18] K. Kohn,et al. Relationships between G1 arrest and stability of the p53 and p21Cip1/Waf1 proteins following gamma-irradiation of human lymphoma cells. , 1995, Cancer research.
[19] F. Mandelli,et al. Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features. , 1995, Blood.
[20] E. Schuuring,et al. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma. , 1995, Oncogene.
[21] M. Raffeld,et al. Involvement of CDKN2 (p16INK4A/MTS1) and p15INK4B/MTS2 in human leukemias and lymphomas. , 1995, Cancer research.
[22] S. Elledge,et al. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells , 1995, Science.
[23] M. Yuille,et al. Deletions and rearrangement of CDKN2 in lymphoid malignancy. , 1995, Blood.
[24] B. Quesnel,et al. p16 gene homozygous deletions in acute lymphoblastic leukemia. , 1995, Blood.
[25] G. Peters,et al. Lack of cyclin D‐Cdk complexes in Rb‐negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. , 1995, The EMBO journal.
[26] W. Mercer,et al. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. , 1995, Cancer research.
[27] Y. Xiong,et al. Deletion of cyclin-dependent kinase 4 inhibitor genes P15 and P16 in non-Hodgkin's lymphoma. , 1995, Blood.
[28] A. Okamoto,et al. IS-12 Mutation and altered expression of P16^ in human cancer. , 1995 .
[29] B. Vogelstein,et al. Absence of WAF1 mutations in a variety of human malignancies. , 1994, Blood.
[30] J. Shay,et al. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. , 1994, Cancer research.
[31] T. Hunter,et al. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age , 1994, Cell.
[32] A. Okamoto,et al. Mutations and altered expression of p16INK4 in human cancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[33] A. López-Guillermo,et al. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma , 1994 .
[34] K. Tanaka,et al. Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias. , 1994, Blood.
[35] M. Pagano,et al. Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for Cyclin D1 function in G1 progression. , 1994, Oncogene.
[36] H. Lovec,et al. Cyclin D1/bcl‐1 cooperates with myc genes in the generation of B‐cell lymphoma in transgenic mice. , 1994, The EMBO journal.
[37] N. Harris,et al. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. , 1994, The American journal of pathology.
[38] B. Coiffier,et al. European Lymphoma Task Force (ELTF): Report of the workshop on Mantle Cell Lymphoma (MCL) , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.
[39] D. Givol,et al. Induction of WAF1/CIP1 by a p53-independent pathway. , 1994, Cancer research.
[40] J. Bartek,et al. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1 , 1994, The Journal of cell biology.
[41] H. Müller-Hermelink,et al. The anaplastic variant of centrocytic lymphoma is marked by frequent rearrangements of the bcl‐1 gene and high proliferation indices , 1994, Histopathology.
[42] R. Weinberg,et al. Function of a human cyclin gene as an oncogene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[43] G. Hannon,et al. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.
[44] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[45] S. Elledge,et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.
[46] Y. Yuasa,et al. Optimization of nonradioisotopic single strand conformation polymorphism analysis with a conventional minislab gel electrophoresis apparatus. , 1993, Analytical biochemistry.
[47] David M. Livingston,et al. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins , 1993, Cell.
[48] R. Weinberg,et al. Physical interaction of the retinoblastoma protein with human D cyclins , 1993, Cell.
[49] S. Pileri,et al. Mantle Cell Lymphoma. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[50] N. Harris,et al. PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[51] O. Melnyk,et al. Characterization of a candidate bcl-1 gene , 1991, Molecular and cellular biology.
[52] M. Raffeld,et al. bcl-1, t(11;14), and mantle cell-derived lymphomas. , 1991, Blood.
[53] A. Arnold,et al. A novel cyclin encoded by a bcl1-linked candidate oncogene , 1991, Nature.
[54] J. Delabie,et al. Translocation (11;14): A cytogenetic anomaly associated with B‐cell lymphomas of non‐follicle centre cell lineage , 1991, The Journal of pathology.
[55] E. Jaffe,et al. Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation. , 1990, Blood.
[56] S. Swerdlow,et al. Genotypic characterization of centrocytic lymphoma: frequent rearrangement of the chromosome 11 bcl-1 locus. , 1990, Blood.
[57] E. Jaffe,et al. Lymphocytic Lymphoma of Intermediate Differentiation: Morphologic and Immunophenotypic Spectrum and Clinical Correlations , 1990, The American journal of surgical pathology.
[58] T. Sekiya,et al. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[59] D. Weisenburger,et al. Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings. , 1987, Blood.